Delivery Order SPE2DB20D2001-SPE2DB25FPNJE
- Not listed
- The Defense Logistics Agency awarded a $3,931.20 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 2.5 mg, a widely used anticoagulant medication. This non-competitive delivery order, issued on April 22, 2025, with an ultimate completion date of April 23, 2025, operates under a firm fixed-price arrangement and represents a single-line pharmaceutical procurement to support federal medical supply needs. The award is being performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,064.70 to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 2.5 mg, a widely used anticoagulant medication. This firm fixed price delivery order, awarded on June 17, 2025, with completion scheduled for June 18, 2025, represents a routine pharmaceutical procurement through the federal medical supply chain. The award was made on a competitive, non-set-aside basis to AmerisourceBergen's Corporate Office located in...
- The Defense Logistics Agency awarded a $23,087.24 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 2.5 mg, a widely prescribed anticoagulant medication. This firm fixed-price delivery order, issued on September 5, 2025, with completion targeted for September 8, 2025, represents a competitive award with no set-aside designation. The pharmaceutical will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $3,931.20 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a widely-used anticoagulant medication. The contract, designated as a firm fixed price delivery order without set-aside provisions, is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This award represents a child contract issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a widely used anticoagulant medication. The award, made on September 4, 2025, with completion targeted for September 5, 2025, utilizes a firm fixed price structure with no set-aside designation, indicating competitive award status. The pharmaceutical will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $15,235.54 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. This firm fixed-price delivery order, awarded on July 28, 2025, with a completion date of July 29, 2025, represents a non-competitive, non-set-aside procurement executed against an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for 60 tablets of Eliquis 2.5 mg, a widely-used anticoagulant medication. The delivery order, valued at $1,965.60 with a firm fixed price, was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025. This award represents a competitive, non-set-aside transaction and will be performed at the...
- The Defense Logistics Agency awarded a $68,634.96 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This firm fixed-price contract, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a non-competitive, non-set-aside award under an existing indefinite delivery contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,896.80 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units). This firm fixed-price delivery order, issued on August 26, 2025, represents a non-competitive award with an ultimate completion date of August 27, 2025. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a widely used anticoagulant medication. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by June 2, 2025. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPNJEDelivery Order
The Defense Logistics Agency awarded a $5,896.80 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 2.5 mg, a widely prescribed anticoagulant medication. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant portfolio of federal contracts with the Defense Logistics Agency and serves critical roles in supporting military and veteran healthcare systems. The company's extensive experience fulfilling federal medical procurement requirements—demonstrated through its versatile delivery orders ranging from under $100 to over $45,000 and encompassing diverse pharmaceutical products across multiple therapeutic domains—underscores its capability as a prime vendor for the Defense Health Agency and other government healthcare systems. This particular delivery order contributes to the company's broader mission of ensuring reliable pharmaceutical supply chains for the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 8/4/25 |